Investment Analysis News 20 December 2025

Intuit (INTU) Stock News, Forecasts and Analyst Outlook: USDC Stablecoin Deal, TurboTax 2026 Tax Push, and Key Catalysts (Dec. 20, 2025)

Dec. 20, 2025 — Intuit Inc. (NASDAQ: INTU) enters the weekend with investors balancing a fresh fintech headline—Intuit’s newly announced USDC stablecoin partnership with Circle—against the familiar seasonal catalyst that often defines the stock’s narrative: TurboTax demand heading into the

20 December 2025

Financial Forecasts·Investment Analysis·Stock Market News

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

International Business Machines Corporation (NYSE: IBM) enters the final stretch of 2025 with its stock consolidating near the $300 level—an area that has become a focal point for both bulls betting on IBM’s “AI + hybrid cloud” strategy and skeptics

20 December 2025

Financial Forecasts·Investment Analysis·Stock Market·Tech Industry

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated (NASDAQ: INSM) is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close (the last U.S.

20 December 2025

Biotech News·Financial Forecasts·Investment Analysis·Stock Market

Texas Instruments Stock (NASDAQ: TXN) on Dec. 20, 2025: Sherman Fab Starts Production, Analysts Split on the 2026 Outlook

December 20, 2025 Texas Instruments Incorporated (NASDAQ: TXN) heads into the weekend at the center of two narratives that rarely collide so neatly: a major U.S. manufacturing milestone and a fresh wave of Wall Street debate about what that investment

20 December 2025

Company News·Financial Forecasts·Investment Analysis·Semiconductor Industry·Stock Market

Goldman Sachs Stock (NYSE: GS): Latest News, Analyst Forecasts, and 2026 Outlook as of December 20, 2025

NEW YORK — December 20, 2025 — Goldman Sachs Group, Inc. (NYSE: GS) is closing out 2025 with momentum: a strong year for big banks, a revived deal pipeline, and fresh headlines that reinforce the firm’s push deeper into AI-driven

20 December 2025

Financial News·Goldman Sachs·Investment Analysis·Market Forecasts·Stock Market

AbbVie Stock (ABBV) News Today: Drug-Pricing Deal Watch, Skyrizi/Rinvoq Momentum, and Fresh Wall Street Forecasts (Dec. 20, 2025)

December 20, 2025 — AbbVie Inc. (NYSE: ABBV) is closing out the week in the spotlight as U.S. drug-pricing policy headlines collide with a still-strong “post-Humira” growth narrative built around Skyrizi and Rinvoq. The stock finished the last regular session

20 December 2025

Drug Pricing·Investment Analysis·Pharma Industry·Stock Market·Wall Street

Data Center Stocks: AI Capex Boom Meets Power-Grid Bottlenecks — Today’s News and 2026 Outlook (Dec. 20, 2025)

December 20, 2025 — Data center stocks have become one of the market’s most crowded (and consequential) intersections: artificial intelligence demand on one side, and real-world constraints—power, land, permitting, and financing—on the other. The investment story isn’t just about more

20 December 2025

Artificial Intelligence·Data Centers·Investment Analysis·Stock Market·Technology Trends

Rare Metals Stocks: Rare Earth Magnet Exports Rebound, Gallium Deals Grow, and Lithium Signals Turn Sharper (Dec. 20, 2025)

Rare metals stocks are ending 2025 with a familiar mix of geopolitics, supply-chain data, and fast-moving technology shifts—only now, the market is increasingly treating “rare metals” as a policy asset class, not just a commodity trade. On December 20, 2025,

20 December 2025

Investment Analysis·Lithium Industry·Stock Market

Alnylam Pharmaceuticals (ALNY) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025

As of Saturday, December 20, 2025, investors are digesting a busy stretch of developments around Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)—from Nasdaq-100 index inclusion (effective Dec. 22) to fresh reimbursement tailwinds in the U.K. and continued focus on Amvuttra (vutrisiran) as

20 December 2025

Analyst Opinions·Biotech Stocks·Financial Forecasts·Investment Analysis·Stock Market News

Qualcomm Stock (QCOM) News, Forecasts and Analysis for December 20, 2025: Alphawave Semi Deal, Insider Sales, and the 2026 Outlook

December 20, 2025 — With U.S. markets closed for the weekend, the latest read on QUALCOMM Incorporated (NASDAQ: QCOM) comes from Friday’s session: QCOM last closed at $175.25 and traded modestly higher in after-hours. StockAnalysis That price point sits at

20 December 2025

Financial News·Investment Analysis·Semiconductor Industry·Stock Market·Technology

Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts

December 20, 2025 — Amgen Inc. (NASDAQ: AMGN) is closing out the year with a rare combination of near-term policy headlines and company-specific catalysts that matter to investors: a new U.S. drug-pricing deal tied to the TrumpRx rollout, fresh FDA

20 December 2025

Dividend Updates·FDA Approvals·Investment Analysis·Pharmaceuticals·Stock Market News

Salesforce (CRM) Stock News and Forecasts on Dec. 20, 2025: Agentforce AI Momentum, Qualified Acquisition, and Wall Street Price Targets

December 20, 2025 — Salesforce, Inc. (NYSE: CRM) stock is heading into the final stretch of 2025 at the center of a debate investors know well: is this a beaten-down software leader becoming a bargain again, or a “value trap”

20 December 2025

AI Technology·Financial Forecasts·Investment Analysis·Salesforce News·Stock Market